EPIX Essa Pharma Inc.

ESSA Pharma Inc is a development stage pharmaceutical company. The Company is engaged in developing proprietary small molecule compound named EPI-506 as a treatment for prostate cancer.

$26.40  +0.80 (3.13%)
As of 02/24/2021 13:02:36 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA

03/13/2015
32,064,411
598,485
$820,848,922
0.00%
SEC Edgar Online
10-Q
10-K
29668H104


Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
11.61
0.00
-34.21%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy